Erschienen in:
01.11.2013 | Research Letter
High frequency of autoantibodies in patients with long duration type 1 diabetes
verfasst von:
Carolyn C. Richardson, James A. Dromey, Kerry A. McLaughlin, Diana Morgan, H. Jonathan Bodansky, Richard G. Feltbower, Anthony H. Barnett, Geoffrey V. Gill, Steven C. Bain, Michael R. Christie
Erschienen in:
Diabetologia
|
Ausgabe 11/2013
Einloggen, um Zugang zu erhalten
Excerpt
To the Editor: It is apparent that small numbers of beta cells are able to survive in the type 1 diabetic pancreas for many years after clinical onset. Thus, insulin-positive islets have been observed in pancreases of patients with long-standing type 1 diabetes, with islets showing evidence of beta cell proliferation, apoptosis and T cell infiltration [
1]. Circulating C-peptide was evident in the majority of Joslin Medalists who survived more than 50 years of diabetes, with age at disease onset and HLA genotype affecting the concentrations detected [
2]. Post-mortem examination of pancreases from nine of these patients demonstrated residual beta cells in all individuals, with beta cell proliferation and T cell infiltration still being evident, even in those with undetectable serum C-peptide [
2]. Although signs of regeneration are not always seen in the diabetic pancreas, these observations suggest that beta cell turnover may occur long after diagnosis of type 1 diabetes, surviving beta cell mass being determined by relative rates of beta cell renewal and autoimmune beta cell destruction. Factors influencing persistence of autoimmunity in long-duration type 1 diabetes have not been widely investigated. In this study we determined the frequencies and levels of antibodies to the diabetes-associated islet autoantigens GAD (GADA), IA-2 (IA-2A) and zinc transporter-8 (ZnT8A) in patients with long-duration type 1 diabetes, and investigated the influence of age at diagnosis and HLA genotype on autoantibody persistence. …